FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+38%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$30.4B
AUM Growth
+$7.6B
(+33%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
34%
Holding
622
New
73
Increased
196
Reduced
171
Closed
128
Top Buys
| 1 |
T-Mobile US
TMUS
|
$436M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$150M |
| 3 |
Shake Shack
SHAK
|
$147M |
| 4 |
Datadog
DDOG
|
$140M |
| 5 |
Lowe's Companies
LOW
|
$109M |
Top Sells
| 1 |
Microsoft
MSFT
|
$206M |
| 2 |
NVIDIA
NVDA
|
$160M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$153M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$136M |
| 5 |
CrowdStrike
CRWD
|
$118M |
Sector Composition
| 1 | Technology | 33.43% |
| 2 | Healthcare | 21.84% |
| 3 | Consumer Discretionary | 15% |
| 4 | Communication Services | 9.98% |
| 5 | Financials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Johnson Controls International
JCI
$69.5B
| $709K | ﹤0.01% |
20,761
| – | – |
|
377
GeoPark
GPRK
$326M
| $685K | ﹤0.01% |
69,944
+66,271
| +1,804% | +$649K |
|
|
MRTX
378
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $685K | ﹤0.01% |
6,000
-3,000
| -33% | -$343K |
|
379
Prologis
PLD
$105B
| $682K | ﹤0.01% |
7,305
| – | – |
|
380
New Oriental
EDU
$7.98B
| $677K | ﹤0.01% |
5,200
-98,423
| -95% | -$12.8M |
|
381
BioNTech
BNTX
$27B
| $667K | ﹤0.01% |
+10,000
| New | +$667K |
|
|
PRVB
382
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $635K | ﹤0.01% |
45,000
+38,000
| +543% | +$536K |
|
383
Afya
AFYA
$1.37B
| $615K | ﹤0.01% |
26,253
-13,500
| -34% | -$316K |
|
384
Accenture
ACN
$159B
| $614K | ﹤0.01% |
2,861
+250
| +10% | +$53.7K |
|
385
Legend Biotech
LEGN
$6.66B
| $608K | ﹤0.01% |
+14,296
| New | +$608K |
|
386
Castle Biosciences
CSTL
$683M
| $603K | ﹤0.01% |
16,000
| – | – |
|
387
Hartford Financial Services
HIG
$37B
| $592K | ﹤0.01% |
15,349
| – | – |
|
|
ENV
388
DELISTED
ENVESTNET, INC.
ENV
| $574K | ﹤0.01% |
7,808
-2,206
| -22% | -$162K |
|
389
Allegion
ALLE
$14.8B
| $572K | ﹤0.01% |
5,600
| – | – |
|
390
Hubbell
HUBB
$23.2B
| $568K | ﹤0.01% |
4,530
+4,414
| +3,805% | +$553K |
|
391
Avidity Biosciences
RNA
$6.48B
| $565K | ﹤0.01% |
+20,000
| New | +$565K |
|
|
ONC
392
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $565K | ﹤0.01% |
+3,000
| New | +$565K |
|
393
Allogene Therapeutics
ALLO
$255M
| $557K | ﹤0.01% |
+13,000
| New | +$557K |
|
394
Electronic Arts
EA
$42.2B
| $549K | ﹤0.01% |
4,159
+647
| +18% | +$85.4K |
|
395
KALA BIO
KALA
$102M
| $526K | ﹤0.01% |
+1,001
| New | +$526K |
|
396
Dow Inc
DOW
$17.4B
| $523K | ﹤0.01% |
12,828
+4,613
| +56% | +$188K |
|
397
Adverum Biotechnologies
ADVM
$73.9M
| $522K | ﹤0.01% |
+2,500
| New | +$522K |
|
398
Incyte
INCY
$16.9B
| $520K | ﹤0.01% |
+5,000
| New | +$520K |
|
399
Oneok
OKE
$45.7B
| $518K | ﹤0.01% |
15,600
| – | – |
|
|
AMRN
400
Amarin Corp
AMRN
$317M
| $498K | ﹤0.01% |
3,600
-400
| -10% | -$55.3K |
|